Randomized, phase III study comparing carboplatin/paclitaxel or carboplatin/paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC)

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00946712?term=S0819&rank=1

2. Intervention

   Carboplatin

3. Intervention

   Paclitaxel

4. Intervention

   Bevacizumab

5. Intervention

   Cetuximab

6. Additional Topic(s)

   Antineoplastic combined chemotherapy protocols

7. Resource Description

   PURPOSE: This randomized phase III trial is studying carboplatin and paclitaxel to compare how well they work with or without bevacizumab and/or cetuximab in treating patients with stage IV or recurrent non-small cell lung cancer.

8. Contact

   Berenberg, Jeffrey

9. PI

   Berenberg, Jeffrey

10. Topic

    lung cancer

11. Study Population

    Males and females age 18 and older with histologically or cytologically confirmed non-small cell lung cancer, including any of the following subtypes: adenocarcinoma, large cell carcinoma, squamous cell carcinoma, or unspecified.

12. Website(s)

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=649817&version=healthprofessional

13. Funded by

    SWOG

14. Phase

    Phase 3 clinical trial

15. Performed by

    Clinical Protocol & Data Management Shared Resource